A case of advanced ovarian cancer effectively treated with a combination of multi-peptide dendritic cell immunotherapy, surgery, and chemotherapy

Personalized Medicine Universe ◽

10.1016/j.pmu.2017.04.003 ◽

2017 ◽

Vol 6 ◽

pp. 28-30

Author(s):

Amane Sasada ◽

Minako Abe ◽

Hiroyuki Abe

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Advanced Ovarian Cancer ◽

Cell Immunotherapy

Download Full-text

DENDRITIC CELL IMMUNOTHERAPY IN OVARIAN CANCER: AN IMMUNOSUPPRESSIVE CHALLENGE

10.26226/morressier.5770e29dd462b80290b4bed8 ◽

2016 ◽

Author(s):

Thaïs Baert

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Cell Immunotherapy

Download Full-text

Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy

OncoImmunology ◽

10.1080/2162402x.2015.1062210 ◽

2015 ◽

Vol 5 (5) ◽

pp. e1062210 ◽

Author(s):

Emese Zsiros ◽

Denarda Dangaj ◽

Carl H. June ◽

Lana E. Kandalaft ◽

George Coukos

Keyword(s):

Ovarian Cancer ◽

T Cell ◽

Dendritic Cell ◽

Tumor Antigen ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Cell Immunotherapy ◽

Significant Barrier ◽

T Cell Immunotherapy

Download Full-text

New approaches in dendritic cell vaccination design and efficacy tests for patients with advanced ovarian cancer: Prospects for a phase I clinical study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps158 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS158-TPS158

Author(s):

M. Imhof

Keyword(s):

Ovarian Cancer ◽

Clinical Study ◽

Dendritic Cell ◽

Phase I ◽

Advanced Ovarian Cancer ◽

Dendritic Cell Vaccination ◽

Download Full-text

Abstract TMIM-077: MYXOMA VIRUS ENHANCES TREATMENT BENEFIT OF CHEMOTHERAPY AND DENDRITIC CELL IMMUNOTHERAPY IN OVARIAN CANCER PRECLINICAL MODEL

10.1158/1557-3265.ovcasymp18-tmim-077 ◽

2019 ◽

Author(s):

Steven J Conrad ◽

Bernice Nounamo ◽

Martin Cannon ◽

Jia Liu

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Myxoma Virus ◽

Preclinical Model ◽

Treatment Benefit ◽

Cell Immunotherapy

Download Full-text

Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer

International Journal of Gynecological Cancer ◽

10.1111/j.1048-891x.2004.014175.x ◽

2004 ◽

Vol 14 (1) ◽

pp. 64-75 ◽

Author(s):

A. D. Santin ◽

S. Bellone ◽

M. Palmieri ◽

B. Bossini ◽

S. Cane' ◽

...

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Advanced Ovarian Cancer ◽

Human Leukocyte ◽

Tumor Infiltrating Lymphocytes ◽

Human Leukocyte Antigens ◽

Cell Stimulation ◽

Leukocyte Antigens ◽

Infiltrating Lymphocytes ◽

Download Full-text

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

Cancer Immunology Immunotherapy ◽

10.1007/s00262-011-1081-8 ◽

2011 ◽

Vol 61 (5) ◽

pp. 629-641 ◽

Author(s):

Christina S. Chu ◽

Jean Boyer ◽

Daniel S. Schullery ◽

Phyllis A. Gimotty ◽

Victoria Gamerman ◽

...

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Phase I ◽

Randomized Trial ◽

Advanced Ovarian Cancer ◽

Dendritic Cell Vaccination ◽

Consolidation Therapy

Download Full-text

Understanding dendritic cell immunotherapy in ovarian cancer

Expert Review of Anticancer Therapy ◽

10.1080/14737140.2016.1178576 ◽

2016 ◽

Vol 16 (6) ◽

pp. 643-652 ◽

Author(s):

Maureen L. Drakes ◽

Patrick J. Stiff

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Cell Immunotherapy

Download Full-text

Dendritic cell immunotherapy in ovarian cancer

Expert Review of Anticancer Therapy ◽

10.1586/era.12.153 ◽

2013 ◽

Vol 13 (1) ◽

pp. 43-53 ◽

Author(s):

Patrick J Stiff ◽

Cheryl Czerlanis ◽

Maureen L Drakes

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Cell Immunotherapy

Download Full-text

A phase I/II trial of IDD-6, an autologous dendritic cell vaccine for women with advanced ovarian cancer in remission

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.12.200 ◽

2011 ◽

Vol 120 ◽

pp. S84

Author(s):

C. Chu ◽

J. Boyer ◽

P. Gimotty ◽

S. Rubin ◽

G. Coukos ◽

...

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Phase I ◽

Advanced Ovarian Cancer ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Autologous Dendritic Cell

Download Full-text

Abstract CT189: Patient-specific dendritic cell vaccines with tumor antigens from self-renewing autologous tumor cells in the treatment of primary advanced ovarian cancer: A multi-institutional phase II clinical trial

10.1158/1538-7445.am2020-ct189 ◽

2020 ◽

Author(s):

Lisa N. Abaid ◽

Bradley R. Corr ◽

James R. Mason ◽

Richard L. Friedman ◽

Ramez N. Eskander ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Trial ◽

Dendritic Cell ◽

Tumor Cells ◽

Phase Ii ◽

Tumor Antigens ◽

Advanced Ovarian Cancer ◽

Patient Specific ◽

Autologous Tumor ◽

Dendritic Cell Vaccines

Download Full-text